IP Library › Granted Patent US 11,650,202
Granted Patent B2
US 11,650,202 · App. 17/650,443 · Granted May 16, 2023

Methods for single molecule analyte detection

Inventors: Bryan P. Staker (San Ramon, CA); Niandong Liu (San Ramon, CA); Bart Lee Staker (Poulsbo, WA); Michael David McLaughlin (San Jose, CA)
Assignee: APTON BIOSYSTEMS, INC.
G01N33/54306G01N33/582C12Q1/6825G01N1/30G01N21/6486G01N33/536G16B25/00G16B40/00H03M13/1515
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,650,202
App. No.
17/650,443
Granted
May 16, 2023
Kind
B2
Abstract

Methods are provided for detecting a single compound analyte immobilized to a solid substrate by serially contacting and removing different probes to the same analyte.

Claims (26)

1. A method of detecting a single compound analyte bound to a solid substrate, said method comprising:

contacting said single compound analyte with a first probe thereby binding said first probe to said single compound analyte, wherein said first probe comprises a first analyte binding component and a first detectable label;

detecting said first detectable label;

removing said first probe from said single compound analyte and said solid substrate;

contacting said single compound analyte with a second probe thereby binding said second probe to said single compound analyte, wherein said second probe comprises a second analyte binding component and a second detectable label;

detecting said second detectable label; removing said second probe from said single compound analyte and said solid substrate;

contacting said single compound analyte with a third probe thereby binding said third probe to said single compound analyte, wherein said third probe comprises a third analyte binding component and a third detectable label; and

detecting said third detectable label thereby detecting the single compound analyte using said first, second, and third detectable labels;

wherein said first detectable label, said second detectable label and said third detectable label are different and wherein said single compound analyte is individually detected.

2. The method of claim 1 , wherein said single compound analyte is spatially separated from other single compound analytes on said solid substrate.

3. The method of claim 1 , wherein said first analyte binding component, said second analyte binding component, and said third analyte binding component are the same.

4. The method of claim 3 , wherein the first analyte binding component, said second analyte binding component, or said third analyte binding component further comprises an oligonucleotide tail region.

5. The method of claim 4 , wherein the first analyte binding component, said second analyte binding component, or said third analyte binding component further comprises a linker region.

6. The method of claim 4 , wherein said oligonucleotide tail comprises a region for polynucleotide synthesis.

7. The method of claim 6 , wherein said oligonucleotide tail comprises a homopolymeric base region of at least 25 nucleotides.

8. The method of claim 7 , wherein said homopolymeric base region comprises one or more stop bases.

9. The method of claim 1 , wherein said first detectable label, said second detectable label and said third detectable label are fluorescent or chemiluminescent.

10. The method of claim 1 , wherein said first detectable label, said second detectable label and said third detectable label are detected optically.

11. The method of claim 1 , wherein said first detectable label, said second detectable label and said third detectable label are detected electrically.

12. The method of claim 1 , wherein said single compound analyte is a protein or oligonucleotide derived from a biological sample.

13. The method of claim 1 , wherein said first analyte binding component, said second analyte binding component, and said third analyte binding component is a protein or oligonucleotide.

14. The method of claim 1 , wherein said first analyte binding component, said second analyte binding component, and said third analyte binding component is an antibody, aptamer or oligonucleotide.

15. The method of claim 1 , wherein said single compound analyte is a protein, peptide, RNA, or DNA.

16. The method of claim 1 , wherein said single compound analyte is a protein, peptide or RNA.

17. The method of claim 1 , wherein said single compound analyte is a cDNA.

18. The method of claim 1 , wherein said single compound analyte is a DNA.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2026
From: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.; APTON BIOSYSTEMS LLC; OMNIOME, LLC
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 075551/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2023
From: APTON BIOSYSTEMS LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 064868/0510 →
MERGER AND CHANGE OF NAME Recorded Aug 29, 2023
From: APTON BIOSYSTEMS, INC.; NEPTUNE ACQUISITION II LLC
To: APTON BIOSYSTEMS LLC
Reel/Frame 064747/0267 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2022
From: STAKER, BRYAN P.; LIU, NIANDONG; STAKER, BART LEE; MCLAUGHLIN, MICHAEL DAVID
To: APTON BIOSYSTEMS, INC.
Reel/Frame 058984/0607 →
Continuity (5)
Continuation 16727732 · Dec 26, 2019
Continuation 14443655
Provisional Application 61869020 · Aug 22, 2013
Provisional Application 61728067 · Nov 19, 2012
Related Publication 20220214335A1 · Jul 7, 2022
Cited By (1)
US 12,234,511